BC is a heterogeneous malignant tumor that varies widely between patients as well as within each single tumor; this is influenced by phenotypic (4) and genetic changes, with/without epigenetic modifications (5), hormonal receptors (6), and alteration, and is also affected by many biological influences as well as metabolic disturbances (7). This evidence concerns the gene NR4A1 and breast cancer.